Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5611)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2022 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garbuzenko DV. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World J Clin Cases 2022; 10(12): 3662-3676 [PMID: 35647163 DOI: 10.12998/wjcc.v10.i12.3662] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v10/i12/3662.htm |
| Number | Citing Articles |
| 1 |
莉 田. Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis. Advances in Clinical Medicine 2022; 12(11): 9816 doi: 10.12677/ACM.2022.12111416
|
| 2 |
Qiying Pei, Qian Yi, Liling Tang. Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(11): 9671 doi: 10.3390/ijms24119671
|
| 3 |
Janitha M. Unagolla, Subarna Das, Riley Flanagan, Marin Oehler, Jyothi U. Menon. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. International Journal of Pharmaceutics 2024; 660: 124381 doi: 10.1016/j.ijpharm.2024.124381
|
| 4 |
Qun Wei, Cailing Gan, Meng Sun, Yuting Xie, Hongyao Liu, Taixiong Xue, Conghui Deng, Chunheng Mo, Tinghong Ye. BRD4: an effective target for organ fibrosis. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00641-6
|
| 5 |
Mengqin Yuan, Lichao Yao, Ping Chen, Zheng Wang, Pingji Liu, Zhiyu Xiong, Xue Hu, Lanjuan Li, Yingan Jiang. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. International Immunopharmacology 2023; 125: 111134 doi: 10.1016/j.intimp.2023.111134
|
| 6 |
Linmao Ye, Jiaxin Huang, Xiaofan Liang, Wenqin Guo, Xiguang Sun, Chang Shao, Yi He, Junjie Zhang. Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-β1/CUGBP1 and IFN-γ/Smad7 pathway. Phytomedicine 2024; 133: 155916 doi: 10.1016/j.phymed.2024.155916
|
| 7 |
Rui Tang, Jing Luo, Xiaoxia Zhu, Pengyu Miao, Hong Tang, Yue Jian, Sibei Ruan, Feng Ling, Mingxi Tang. Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1258870
|
| 8 |
Nan Wu, Meiyi Song, Fan Zhang, Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou. Dysregulation of sphingolipid metabolism in liver fibrosis. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.38
|
| 9 |
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications. Biomedicine & Pharmacotherapy 2024; 177: 117003 doi: 10.1016/j.biopha.2024.117003
|
| 10 |
Jea Il Kim, Hyae Gyeong Cheon. Melatonin ameliorates hepatic fibrosis via the melatonin receptor 2-mediated upregulation of BMAL1 and anti-oxidative enzymes. European Journal of Pharmacology 2024; 966: 176337 doi: 10.1016/j.ejphar.2024.176337
|
| 11 |
Qing-Qing Liu, Jing Chen, Tao Ma, Wei Huang, Cui-Hua Lu. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59698-w
|
| 12 |
Ying Cao, Huan Yang, Bingying Wang. CircRNA_001373 promotes liver fibrosis by regulating autophagy activation in hepatic stellate cells via the miR-142a-5p/Becn1 axis. Human & Experimental Toxicology 2024; 43 doi: 10.1177/09603271241265105
|
| 13 |
Jianhao Jiang, Ilgiz Gareev, Tatiana Ilyasova, Alina Shumadalova, Weijie Du, Baofeng Yang. The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis. Non-coding RNA Research 2024; 9(2): 463 doi: 10.1016/j.ncrna.2024.01.001
|
| 14 |
Jin-Pei Liu, Shao-Hua Song, Pei-Mei Shi, Xiao-Yu Qin, Bai-Nan Zheng, Shu-Qing Liu, Chen-Hong Ding, Xin Zhang, Wei-Fen Xie, Yi-Hai Shi, Wen-Ping Xu. miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03174-2
|
| 15 |
Xiaoxue Hou, Yuwen Li, Jiali Song, Linya Peng, Wen Zhang, Rui Liu, Hui Yuan, Tiantong Feng, Jieying Li, Wenting Li, Chuanlong Zhu. METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2–dependent mechanism. Hepatology Communications 2023; 7(8) doi: 10.1097/HC9.0000000000000199
|
| 16 |
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer. Natural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
|
| 17 |
Yiheng Zhang, Mulan Xing, Fansheng Meng, Ling Zhu, Qingchuan Huang, Tianle Ma, Huihua Fang, Xujing Gu, Suzhou Huang, Xinyu Wu, Gaohong Lv, Jun Guo, Li Wu, Xin Liu, Zhipeng Chen. The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension. European Journal of Cell Biology 2024; 103(2): 151427 doi: 10.1016/j.ejcb.2024.151427
|
| 18 |
Xiao-Xue Hou, Yu-Wen Li, Jia-Li Song, Wen Zhang, Rui Liu, Hui Yuan, Tian-Tong Feng, Zheng-Yi Jiang, Wen-Ting Li, Chuan-Long Zhu. Cryptotanshinone induces apoptosis of activated hepatic stellate cells <i>via</i> modulating endoplasmic reticulum stress. World Journal of Gastroenterology 2023; 29(17): 2616-2627 doi: 10.3748/wjg.v29.i17.2616
|
| 19 |
Weijing Lai, Bo Wang, Rongshuang Huang, Chuyue Zhang, Ping Fu, Liang Ma. Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines. Journal of Translational Internal Medicine 2024; 12(1): 22 doi: 10.2478/jtim-2023-0137
|
| 20 |
Mohammed Sohel Meah, Pharkphoom Panichayupakaranant, Mohammed Abu Sayeed, Min Gab Kim. Isolation and Pharmacochemistry of
α-Mangostin as a Chemotherapeutic Agent. Pharmacognosy Magazine 2024; doi: 10.1177/09731296241262567
|
| 21 |
Irina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, Eduardo E. Vargas-Pozada, Verónica Rocío Vásquez-Garzón, Saúl Villa-Treviño, Pablo Muriel. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicology Mechanisms and Methods 2024; 34(1): 13 doi: 10.1080/15376516.2023.2244061
|
| 22 |
Keiya Watakabe, Masato Miyoshi, Sei Kakinuma, Ayako Sato, Jun Tsuchiya, Taro Shimizu, Tomohiro Mochida, Kento Inada, Shun Kaneko, Fukiko Kawai‐Kitahata, Miyako Murakawa, Sayuri Nitta, Mina Nakagawa, Shigeru Oshima, Mamoru Watanabe, Averil Ma, Yasuhiro Asahina, Ryuichi Okamoto. A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1–JNK pathway‐dependent chemokines. The FASEB Journal 2024; 38(13) doi: 10.1096/fj.202400109R
|
| 23 |
Mphatso Mayuni Chaponda, Ho Yin Pekkle Lam. Schistosoma antigens: A future clinical magic bullet for autoimmune diseases?. Parasite 2024; 31: 68 doi: 10.1051/parasite/2024067
|
| 24 |
Osama A. Mohammed, Mahmoud E. Youssef, Ahmed S. Doghish, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Mushabab Alghamdi, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I.E. Adam, Muffarah Hamid Alharthi, Abdullah Hassan Alhalafi, Emad Bahashwan, Assad Ali Rezigalla, Daad Fuad BinAfif, Sameh Abdel-Ghany, Mohammed A. Attia, Elsayed A. Elmorsy, Tohada M. AL-Noshokaty, Heba Fikry, Lobna A. Saleh, Sameh Saber. A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis. European Journal of Pharmaceutical Sciences 2024; 198: 106792 doi: 10.1016/j.ejps.2024.106792
|